National Health Investors (NHI) is set to join the S&P SmallCap 600 index, a move that can draw more attention from index funds and ETFs and influence trading activity in the stock.

Recent trading reflects this shift in attention, with National Health Investors posting a 9.5% 7 day share price return and a 14.8% 1 year total shareholder return. Its 90 day share price return is down 5.7%, suggesting shorter term momentum has softened even as longer term returns remain positive.

If this index move has you thinking about where else capital could work, it may be worth scanning opportunities in companies powering the grid and electrification story with the 35 power grid technology and infrastructure stocks

With National Health Investors trading at $77.55 and implying a discount to both analyst targets and some intrinsic estimates, the key question is whether investors are overlooking value or already pricing in the REIT's future growth potential.

Most Popular Narrative: 9.6% Undervalued

On the most followed narrative, National Health Investors is priced below an estimated fair value of $85.75, which is higher than the latest $77.55 close, putting more focus on what is driving that gap.

NHI's focused expansion of its SHOP (Senior Housing Operating Portfolio) segment, with double-digit NOI growth projected and a robust pipeline of accretive acquisitions, positions the company for outsized multi-year NOI and earnings growth relative to peers.

Want to understand why this narrative still supports a premium earnings multiple and higher fair value? The answer sits in the revenue path, margin assumptions, and how long that growth runway is expected to last.

Result: Fair Value of $85.75 (UNDERVALUED)

However, this narrative can be tested quickly if National Health Investors experiences prolonged softness in SHOP occupancy, or if equity-funded growth leads to meaningful shareholder dilution.

Another View: National Health Investors Through Earnings Multiples

While the most followed narrative sees National Health Investors as 9.6% undervalued against an $85.75 fair value, the current 25.4x P/E tells a more mixed story. It sits above the global Health Care REITs average of 20x, yet below a 32.7x fair ratio and a 47.6x peer average. This points to both upside and re-rating risk if sentiment or earnings expectations change. How comfortable are you with that kind of valuation gap on a slow growing earnings profile?

Next Steps

If the mixed sentiment around National Health Investors has you on the fence, you may want to take a closer look at the trade off between concern and optimism by reviewing the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond National Health Investors?

Do not stop with National Health Investors. Broaden your watchlist now with fresh stock ideas that align with different goals so you are not missing potential opportunities.

• Target reliable income by reviewing companies that currently offer robust payout profiles through the 8 dividend fortresses.
• Look for quality at a potential discount by scanning companies that meet strict value and fundamentals filters with the 44 high quality undervalued stocks.
• Emphasize capital protection by focusing on companies that show resilient financial profiles using the 71 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.